Clinical Trials Browser

Phase 3 × Not yet recruiting × Glutamine × Clear all

NCT07287592 2025-12-17

Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.

Phase 3 Not yet recruiting

Neoplasms